PCSK9 and systemic inflammatory response syndrome: Of clinical relevance, the 21 COVID-19 patients with sepsis had higher plasma PCSK9 levels in comparison with the SIRS/sepsis patients not infected with SARS-CoV-2 (Figure 2c).